2016 International Congress

Monday, June 20, 2016

12:30pm-2:00pm

Clinical and polysomnographic features correlates to sleep-disordered breathing in multiple system atrophy

B. Cao, Q. Wei, R. Ou, B. Zhao, T. Hu, H. Shang (Chengdu, People's Republic of China)

Parkinsonism, MSA, PSP

12:30pm-2:00pm

Clinical characteristics of Parkinson’s disease and essential tremor patients undergoing deep brain stimulation surgery: Five-year data from Columbia University Medical Center (2009 – 2014)

M. Kestenbaum, D. Robakis, B. Ford, R.N. Alcalay, E.D. Louis (Tel Aviv, Israel)

Surgical therapy: Parkinson's disease  ·  Exhibit Hall located in Hall B, Level 2

12:30pm-2:00pm

Clinical correlates of depression and anxiety in patients with Parkinson’s disease

H.D. Hambardzumyan, H.M. Manvelyan (Yerevan, Armenia)

Parkinson's disease: Non-motor symptoms  ·  Exhibit Hall located in Hall B, Level 2

12:30pm-2:00pm

Clinical efficacy of istradefylline on lower urinary tract symptoms in Parkinson’s disease: A prospective study

T. Kitta, I. Yabe, Y. Kanno, H. Chiba, K. Moriya, I. Takahashi, M. Matsushima, H. Sasaki, N. Shinohara (Sapporo, Japan)

Parkinson's disease: Non-motor symptoms  ·  Exhibit Hall located in Hall B, Level 2

12:30pm-2:00pm

Clinical features of Parkinson’s disease patients developing stridor with acute respiratory failure

J. Tashiro, S. Hamada, H. Soma, M. Nonaka, S. Honma, K. Hamada, A. Takei, F. Moriwaka, K. Tashiro (Sapporo, Japan)

Parkinson's disease: Non-motor symptoms  ·  Exhibit Hall located in Hall B, Level 2

12:30pm-2:00pm

Clinical outcome of constant current deep brain stimulation in patients with medication-refractory essential tremor

A. Rezaei Haddad, K. Ashkan (Coventry, United Kingdom)

Surgical therapy: Other movement disorders  ·  Exhibit Hall located in Hall B, Level 2

12:30pm-2:00pm

Clinical outcome of subthalamic deep brain stimulation in Parkinson’s disease – The Helsinki experience

M. Koivu, A. Huotarinen, F. Scheperjans, R. Kivisaari, E. Pekkonen (Helsinki, Finland)

Surgical therapy: Parkinson's disease  ·  Exhibit Hall located in Hall B, Level 2

12:30pm-2:00pm

Clinical phenotype (motor and neuropsychological presentation) and neuroimaging in Sardinian patients affected by atypical parkinsonisms, carriers of 20-22 repeats of C9ORF72 hexanucleotide expansion

G. Orofino, A. Cannas, P. Solla, M.M. Mascia, M.R. Murru, G. Borghero (Monserrato, Italy)

Parkinsonism, MSA, PSP (secondary and parkinsonism-plus)  ·  Exhibit Hall located in Hall B, Level 2

12:30pm-2:00pm

Clinical predictors of progressive supranuclear palsy (PSP) pathology in PSP syndrome

I. Aiba, Y. Saito, Y. Yokokawa, M. Kenjo, T. Katayama, R. Hashimoto, S. Sakakibara, A. Inukai, M. Mimuro, Y. Iwasaki, M. Yoshida (Nagoya, Japan)

Parkinsonism, MSA, PSP (secondary and parkinsonism-plus)  ·  Exhibit Hall located in Hall B, Level 2

12:30pm-2:00pm

Clinical profile and outcome of hospitalized patients with Parkinson’s disease

P. Chatterjee, K. Chatterjee, R. Banerjee, S. Choudhury, B. Mondal, M. Ummekulsum, S.S. Jha, S. Chatterjee, S.S. Anand, H. Kumar (Kolkata, India)

Parkinson's disease: Non-motor symptoms  ·  Exhibit Hall located in Hall B, Level 2